N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
A phase 2 trial of Bevacizumab and Nogapendekin alfa inbakicept in glioma & glioblastoma, run by ImmunityBio, Inc., active and no longer recruiting.
Overview
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma is a phase 2 interventional study registered as NCT06061809 by ImmunityBio, Inc., with 34 participants enrolled, started 2024-08-07 and due to reach its primary completion in 2029-12-31. Interventions recorded: Bevacizumab, PD-L1 t-haNK, N-803 and Tumor Treating Fields (TTFields, 200 kHz).
Similar pages
not linked directly; found by shared links- TrialClinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
Shares ImmunityBio, Nogapendekin alfa inbakicept and the tag pipeline.
- TrialCombination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
Shares ImmunityBio, Nogapendekin alfa inbakicept and the tag pipeline.
- TrialA Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
Shares ImmunityBio and the tag pipeline.
- TrialA Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
Shares Bevacizumab, Glioma & glioblastoma and the tag pipeline.
- TrialGlioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
Shares Bevacizumab, Glioma & glioblastoma and the tag pipeline.
- TrialStudy of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma
Shares ImmunityBio and the tag pipeline.
- TrialA Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma
Shares Bevacizumab, Glioma & glioblastoma and the tag pipeline.
- TreatmentCD19 t-haNK
Shares ImmunityBio and the tag pipeline.